Aspen Aerogels (ASPN) Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024 summary
Event summary combining transcript, slides, and related documents.
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024 summary
9 Jul, 2026Recent financial and operational performance
Revenue guidance was raised twice in 2024, now targeting $390 million, with EBITDA guidance up to $60 million.
Gross margin improved from 11% to 44% over recent quarters, driven by fixed cost absorption and increased capacity utilization, especially in the EV thermal barrier business.
Current asset and supply arrangements support $650 million in revenue capacity, with potential expansion to $800–$850 million as operational improvements are realized.
Energy industrial business remains strong, with a switch to external manufacturing in China boosting margins and enabling plans to double business size over four years.
DOE loan for a new Georgia plant is in interagency review, expected to fund the remainder of the project after $300 million equity investment.
Market outlook and customer programs
Regulatory requirements will push U.S. OEMs to achieve at least a 15% EV mix by 2026, translating to over 400,000 EVs for key customers.
New customer programs with Audi, Stellantis, Porsche, and Scania are expected to impact financials from late 2025, with another large European OEM announcement anticipated by year-end.
Energy industrial segment is expanding into LNG and carbon capture, with Cryogel products now 25% of revenue mix and two carbon capture wins.
The business expects to double energy industrial revenue capacity in four years, leveraging a strong partnership in China.
Competitive landscape and innovation
EV thermal barrier solutions offer superior thermal isolation and fireproofing compared to polyurethane foam and ceramic alternatives, with significant IP protection.
High barriers to entry for competitors due to IP, capital, scale, and OEM relationships.
R&D efforts continue in silicon battery materials and carbon aerogel, aiming to move from lab to pilot scale with potential for grants or partnerships.
The company’s technology platform is leveraged for sustainability-focused markets, supporting long-term growth.
Latest events from Aspen Aerogels
- Record 2024 revenue, margin expansion, and capital-light strategy support resilient outlook.ASPN
Q4 20248 Jul 2026 - All proposals passed, including director elections and board declassification.ASPN
AGM 202619 May 2026 - Q1 2026 revenue dropped, but net loss improved and strong cash reserves support recovery.ASPN
Q1 20268 May 2026 - Virtual annual meeting to vote on directors, auditor, compensation, and board structure.ASPN
Proxy filing27 Mar 2026 - Proxy covers director elections, auditor ratification, executive pay, and board declassification.ASPN
Proxy filing27 Mar 2026 - Annual meeting covers director elections, pay, auditor ratification, and board declassification.ASPN
Proxy Filing13 Mar 2026 - Cost discipline, European wins, and energy industrial growth support 2026 recovery.ASPN
Q4 202525 Feb 2026 - Record Q2 revenue and profitability drive raised 2024 outlook and margin expansion.ASPN
Q2 20242 Feb 2026 - $225M debt facility redeems convertible note, lowers capital costs, and supports future growth.ASPN
Status Update23 Jan 2026